Back to Journals » Cancer Management and Research » Volume 13

Real-World Analysis of the Efficacy and Safety of a Novel Irreversible HER2 Tyrosine Kinase Inhibitor Pyrotinib in Patients with HER2-Positive Metastatic Breast Cancer

Total article views   HTML views PDF downloads Totals
4,368 Dovepress* 3,999+ 354 4,353
PubMed Central* 369 177 546
Totals 4,368 531 4,899
*Since 14 September 2021
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar